[Induction of malignant tumors in the corpus uteri of the mouse by 20-methylcholanthrene, and the influence of simultaneous gestagen treatment on histological structure and DNA stemlines of tumors].
D000230:Adenocarcinoma / Q000139:chemically induced*; D000818:Animals; D002208:Caproates / Q000494:pharmacology; D002294:Carcinoma, Squamous Cell / Q000139:chemically induced*; D004273:DNA, Neoplasm / Q000032:analysis; D004171:Diploidy; D005260:Female; D049673:History, 20th Century; D006908:Hydroxyprogesterones; D008748:Methylcholanthrene; D051379:Mice; D009654:Norsteroids / Q000494:pharmacology; D011123:Polyploidy; D011278:Pregnanes / Q000494:pharmacology; D011372:Progestins / Q000494:pharmacology; D012513:Sarcoma, Experimental / Q000139:chemically induced*; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000139:chemically induced* / Q000473:pathology; D014599:Uterus / Q000187:drug effects
D002208:Caproates; D004273:DNA, Neoplasm; D006908:Hydroxyprogesterones; D009654:Norsteroids; D011278:Pregnanes; D011372:Progestins; D008748:Methylcholanthrene
Die Erzeugung maligner Tumoren im Corpus uteri der Maus mit 20-Methylcholanthren und die Beeinflussung der histologischen Struktur sowie der DNS-Stammlinien der Tumoren durch gleichzeitige Gestagen-Behandlung.